Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy

American Journal of Neuroradiology

Volumn 22, Issue 5, 2001, Pages 977-984

  Thurnher, Majda M ^a   Post, M Judith Donovan ^b   Rieger, Armin ^a   Kleibl Popov, Christina ^a   Loewe, Christian ^a   Schindler, Erwin ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISEASE COURSE; DRUG EFFECT; EVALUATION; FEMALE; FOLLOW UP; HUMAN; IMAGING; LEUKOMALACIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RADIODIAGNOSIS; SURVIVAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATROPHY; BRAIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; SURVIVAL ANALYSIS;

EID: 0035039782     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Berger JR, Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. Neurovirol 1995;1:5-18
2. Happe S, Besselmann M, Matheja P, et al. Therapy of progressive multifocal leukoencephalopathy (PML) in AIDS with cidofovir (Vistide): review of the literature and two case reports. Nervenarzt 1999;70:935-943
3. Portegies P, Algra PR, Hollak CEM, et al. Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1991:337:680-681
4. Nicoli F, Chave B, Peragut JC, Gastaut JL. Efficacy of cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1991;339:306
5. De Luca A, Giancola ML, Cingolani A, et al. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 1999;28:624-628
6. Miralles P, Berenguer J, Garcia de Viedma D, et al. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 1998;12: 2467-2472
7. Tassie JM, Gasnault J, Bentata M, et al. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. AIDS 1999;13:1881-1887
8. Giudici B, Vaz B, Bossolasco S, et al. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 2000;30:95-99
9. Baqi M, Kucharczyk W, Walmsley SL. Regression of progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 1997;11:1526-1527
10. Teofilo E, Gouveia J, Brotas V, da Costa P. Progressive multifocal leukoencephalopathy regression with highly active antiretroviral therapy. AIDS 1998:12:449
11. Whiteman MLH, Post MJD, Berger JR, Tate LG, Bell MD, Limonte LP. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993;187:233-240
12. Post MJD, Yiannoutsos C, Simpson D, et al. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AJNR Am J Neuroradiol 1999;20:1896-1906
13. Thurnher MM, Thurnher SA, Mühlbauer B, et al. Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI. Neuroradiology 1997;39:611-618
14. Kuchelmeister K, Gullotta F, Bergmann M, Angeli G, Masini T. Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS): a neuropathological autopsy study of 21 cases. Pathol Res Pract 1993;189:163-173
15. Dörries K. Virus-host interactions and diagnosis of human Polyomavirus-associated disease. Intervirology 1996;39:165-175
16. Wheeler AL, Truwit CL, Kleinschmidt-DeMasters BK, Byrne WR. Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR imaging. AJR Am J Roentgenol 1993;161:1049-1051
17. Port JD, Miseljic S, Lee RR, et al. Progressive multifocal leukoencephalopathy demonstrating contrast enhancement on MRI and uptake of thallium-201: a case report. Neuroradiology 1999;41:895-898
18. Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 1998;44:341-349
19. Kotecha N, George MJ, Smith TW, Corvi F, Litofsky NS. Enhancing progressive multifocal lenkoencephalopathy: an indicator of improved immune status. Am J Med 1998;105:541-543
20. Woo HH, Rezai AR, Knopp EA, et al. Contrast-enhancing progressive multifocal leukoencephalopathy: radiological and pathological correlations: case report. Neurosurgery 1996;39: 1031-1035
21. Collazos J, Mayo J, Martinez E, Blanco MS. Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS 1999;13:1426-1428
22. Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K. Transactivation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci U S A 1990;87:3479-3483
23. Entning RH, Hoetelmans MW, Lange JMA, Burger DM, Beijnen JH, Portehies P. Antiretroviral drugs and the central nervous system. AIDS 1998;12:1941-1955
24. Flexner C. HIV-protease inhibitors. N Engt J Med 1998;338: 1281-1292
25. Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ. Progressive multifocal leukoencephalopathy in AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 1999;28:1152-1154
26. Mayo J, Collazos J, Marlinez E. Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy. AIDS 1998;12:1720-1722